1. Alferova IV, Vostrov SN, Portnoy YA et al (2005) Comparative pharmacodynamics of telithromycin and clarithromycin with Streptococcus pneumoniae and Staphylococcus aureus in an in vitro dynamic model: focus on clinically achievable antibiotic concentrations. Int J Antimicrob Agents 26:197–204
2. Ambrose PG, Bhavnani SM, Rubino CM et al (2007) Pharmacokinetics-pharmacodynamics of antimicrobial therapy: it’s not just for mice anymore. Clin Infect Dis 44:79–86
3. Amsden GW (2001) Advanced-generation macrolides: tissue-directed antibiotics. Int J Antimicrob Agents 18(Suppl 1):S11–S15
4. Amsden GW, Nafziger AN, Foulds G (1999) Pharmacokinetics in serum and leukocyte exposures of oral azithromycin, 1,500 milligrams, given over a 3- or 5-day period in healthy subjects. Antimicrob Agents Chemother 43:163–165
5. Andes DR, Okusanya OO, Forrest A et al (2010) Pharmacokinetic-pharmacodynamic (PK-PD) analysis of Solithromycin against Streptococcus pneumoniae using data from a murine-lung infection model. In: 50th Interscience conference on antimicrobial agents and chemotherapy (ICAAC), Boston, MA A1-688